Products & Services, Business & People
EMA: First particular replacement remedy for treating rare bleeding disorder
The European Medicines Agency (EMA) has recommended granting a marketing authorization for Coagadex (human coagulation factor X) to treat factor X deficiency, a rare inherited bleeding disorder.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you